Social Flashcards

1
Q

Establishing Advanced Care / discussing goals of care?

A

If the patient has a good understanding of their prognosis:

  • I believe that it is a reasonable time to begin discussing Advanced Care with him/her as he/she has a reasonable understanding of his/her prognosis.
  • I would focus initially on building rapport in order to gain trust.

If the patient has poor insight into their prognosis:

  • Given that patient has relatively limited insight into their prognosis, attempting to discuss Advanced Care too abruptly may have a negative impact.
  • For this reason, I would focus initially on building rapport in order to gain trust.
  • Then I would focus on improving his insight into his disease and how it can impact on his/her prognosis, in a sensitive manner
  • Only once I am confident that he has a reasonable understanding of their prognosis, I would begin goals of care discussion

Then…

This conversation can be emotionally difficult for the patient.

  • Build Rapport & gain his trust
  • Check with patient who she/he wants to be involved in discussion
  • Organise a family meeting
  • In a sensitive manner, I’d layout information on the current disease state & prognosis
  • I’d like to spend more time to understand his belief & values
  • Based on my discussion with the patient, the most important thing for him/her is …… (e.g. QOL, living to son’s 1st school day…etc)
  • Therefore I would ensure that this patient’s Advanced care planning is in line with these priorities
  • And I would document this so that it is clearly communicated to other healthcare professionals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Monitoring & Surveillance for Psychological Impact of Advanced Comorbidities

A

I am concerned about his/her psychological well-being in the future.

Why is it happening? (Risk factors)

I feel that this patient is at risk because…(describe risk factors)

  • Can’t do what they enjoyed the most due to disease
  • Progressively losing their independence
  • Previous depression
  • Social isolation
  • Other reasons

Why is this important?

  • Reduce self-efficacy
  • Impact on adherence to therapy and follow-up
  • Increased risk of suboptimal disease control & complications

What am I going to do?

  • Screen for depressive symptoms every 3-6 monthly using DSM-5 criteria
  • Non-pharm
    • Enlist family & friend’s support
    • Encourage healthy lifestyle: ETOH moderation, exercise, good sleep hygiene, balanced diet, mild-body programs (e.g. yoga)
    • Increase social interaction: community groups, support groups
    • Resources: Black dog institute (MH support), Lifeline (crisis support)
    • CBT - medicare subside 10 sessions. Identify, challenge and modify mal-adaptive behaviours
    • Counseling
  • Pharm
    • Mirtazapine (if under-weight) - improves sleep and appetite (15mg start, max 45mg)
    • SNRI (e.g. Venlafaxine, Duloxetine 20mg) - better for fat people
    • Start low and gradual increase
    • _Monitor for side effect_s
      • Sedation, Insomnia, Seizure
      • GI side effects
      • Hyponatremia
      • Sexual dysfunction
      • Anti-cholinergic
      • Prolonged QT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Addressing Health Literacy / Lack of Insight

A

Why is it happening (state risk factors for this patient)

  • The complexity of medical issues
  • Lack of explanation
  • Limited education - “next thing is education. He is educated up to…he should/may have difficulty understanding with only one off explanation. I’d really like to spend some time explaining things clearly…”
  • Mood disorders / Cognitive impairment (unlikely in long case) - “There might be an another aspect of his health literacy” - “I’d like to ensure that mood is not a playing a role”
  • Lack of taking ownership of their own health

Why is it important (Impact)

  • Adherence
  • Foster self-efficacy
  • Long-term outcome

Plan

  • Dedicated session
  • Speak slowly in moderate pace
  • Prioritise content to discuss - limit to 3
  • Repeat & confirm that they understand
    • Seek GP & family support
    • Website
    • Community groups
  • Written information
  • Visual aids
  • Encourage patient participation: encourage patient to ask questions - have 2-3 questions ready for next appointment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Addressing Compliance/Adherence issues?

A

Why is it happening? (list risk factors for this patient)

  • Patient: busy life (forgets), insight, level of education, lack of belief in the treatment, simply forgets, cannot afford
  • Disease: asymptomatic / patient used to symptoms
  • Doctor: inadequate follow-up, poor relationship
  • Medications: cost, dosing, pill burden, the barrier to obtaining medications, side effects

Why is it important?

  • Impact on disease outcome
  • Complications

Plan

  • Address specific cause for this patient
  • General
    • Educate
    • Reminders: phone apps, sticky notes, keep the pills where patient goes for breakfast
    • Pillbox, webster pack
    • Generic medications (cost)
    • Rationalise medications
    • Simplify dosing regimes - slow release, once daily
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Addressing ETOH excess.

A

Goals:

  • Encouraging Abstinence from ETOH / or decrease consumption
  • Prevent complications

Cessation of ETOH / or decrease consumption

  • Why are they drinking? Address psychosocial factors.
  • Manage withdrawals
  • Inpatient if high-risk of seizures or DT, otherwise outpatient
  • BDZ based on AWS: regular diazepam or oxazepam if there is liver dysfunction​​
  • eTG 2016 –> diazepam 20mg q2h max dose 60mg daily for withdrawal symptoms
  • Thiamine 300mg TDS IV/IM for 5 - 7 days then 300mg daily thereafter
  • FLAGS
    • Organise dedicated session
    • Feedback: educate on harms of alcohol, especially if has no insights
    • Listen to their concerns (e.g. are they afraid of withdrawals)
    • Advice on benefits (financial, social, medical)
    • G: set a specific goal
      • Avoiding friends who drinks too much
      • Not having ETOH at home
      • Spacing out drinks
    • S: set a Strategy based on what the patient is willing to try.
      • Reinforce patient - show belief that he/she can make a change
  • Non-pharm
    • Involve family for support & psychology involvement
    • Motivational interviewing - to help resolve ambivalence about change
    • CBT: helping them to identify mal-adaptive thought process & encouraging positive adaptive behaviours
    • Mutual help groups such as AA
    • These can also be done via online
  • Pharm (1st line = Naltrexone / Acamprosate)
    • Naltrexone > acamprosate: one tablet 1/day, more effective, however cannot be used in the advanced liver. Cannot be given to opioid users (since it is opioid antagonist)
      • Can be started while drinking
      • Monitor LFTs
    • Acamprosate: TT TDS, less effective, but safe in liver failure. Needs dose adjustment for renal impairment. Contraindicated in renal failure
    • Topiramate

Monitor complications

  • History & exam: CCF, CLD, cerebellar dysfunction, PN, WKorsakoff’s, social
  • Ix: ECG, LFTs, FBC (BM, macrocytic anaemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Addressing Smoking

A

Goals

  • Improve awareness of its harms
  • Cessation
  • Relapse prevention

Dedicated session to offer education & advice

  • Feedback on harms of smoking
  • Listen to their concerns
  • Advice on benefits of quitting - financial & health
  • Goal: set a quit date (not smoking less cigarette - ineffective)
  • offer Strategies - pharmacological & non-pharmacological

Non-pharmacological

  • Enlist the support of family & friends
  • ***Warn potential AEs of quitting
    • Explain that these are short lasting: weight gain, irritability, depression
  • Dealing with craving: _alternative activitie_s, e.g. exercise
  • Written information packs: benefits, harm, side effects of quitting
  • Address barriers as much as possible: ETOH, friends, social situation, Caffeine
  • Refer to QUITLINE or smoking cessation clinic
  • Relapse rate is highest in the 1st week (50%) - so I will follow-up weekly for the first 2 weeks (then GP f/u regularly)

Pharmacological

  • NRT (14-21mcg/d): angina, arrhythmia, cardiac
  • Varenicline (nicotine R partial agonist): abnormal dreams, epilepsy, psych
  • Bupropion: Bulimia, Brain issues (insomnia, seizures)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Addressing geographic isolation

A

Why is it happening?

  • State patient-specific factors

Why is it important

  • Difficulty attending appointments and getting medications
  • Challenging emergency care
  • Risk for social isolation + mental disorders

Management

  • Screen and treat depression & cognitive impairment
  • Ensure an Action plan is in place, including contact numbers
  • Simplify: pool appointments together
  • Home deliver meds
  • Make use of Telehealth & skype
  • Community transport
  • Ensure patient is on eligible support scheme (e.g. NDIS)
  • Engage outreach services
How well did you know this?
1
Not at all
2
3
4
5
Perfectly